The effect of bacterial adjuvants on allograft survival after anti-lymphocyte serum (ALS) and donor bone marrow in mice.
D000276:Adjuvants, Immunologic; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001500:BCG Vaccine; D001419:Bacteria / Q000276:immunology*; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D001886:Bordetella pertussis / Q000276:immunology; D006084:Graft Rejection; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008809:Mice, Inbred C3H; D009163:Mycobacterium bovis / Q000276:immunology; D010567:Pertussis Vaccine / Q000008:administration & dosage; D011425:Propionibacterium acnes / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D016038:Skin Transplantation; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000961:Antilymphocyte Serum; D001500:BCG Vaccine; D010567:Pertussis Vaccine